Interaction of amifostine and ionizing radiation on transcriptional patterns of apoptotic genes expressed in human microvascular endothelial cells (HMEC)

International Journal of Radiation Oncology Biology Physics

Volumn 60, Issue 2, 2004, Pages 553-563

  Khodarev, Nikolai N ^a   Kataoka, Yasushi ^a   Murley, Jeffrey S ^a   Weichselbaum, Ralph R ^a   Grdina, David J ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Amifostine; Apoptosis; DNA arrays; Expression profiling; Gene expression; WR 1065

Indexed keywords

ASSAYS; CELLS; CHEMOTHERAPY; ONCOLOGY; PATIENT MONITORING; PATIENT TREATMENT; PROTEINS; RADIOTHERAPY;

ENDOTHELIAL CELLS; FLOW CYTOMETRY; RADIOPROTECTIVE EFFECTS; TRANSCRIPTIONAL PATTERNS;

GENES;

2 (3 AMINOPROPYLAMINO)ETHANETHIOL; AMIFOSTINE; ATM PROTEIN; CASPASE; CASPASE 2; CASPASE 9; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLIN A; CYCLIN D3; FAS LIGAND; HEAT SHOCK PROTEIN 27; INDUCIBLE NITRIC OXIDE SYNTHASE; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEIC ACID BINDING PROTEIN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; PROTECTIVE AGENT; PROTEIN BCL 2; PROTEIN KINASE LCK; PROTEIN P57; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE; RAF PROTEIN; RNA POLYMERASE II; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; TUMOR NECROSIS FACTOR RECEPTOR 1; TYROSINE 3 MONOOXYGENASE; UNINDEXED DRUG;

APOPTOSIS; ARTICLE; CELL CYCLE PHASE; CELL GROWTH; CELL PROTECTION; CELL SURVIVAL; CLONOGENIC ASSAY; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFECT; DRUG MECHANISM; FLOW CYTOMETRY; GENE ACTIVATION; GENE EXPRESSION; GENE REPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IONIZING RADIATION; PRIORITY JOURNAL; RADIATION DOSE; RADIATION EXPOSURE; VASCULAR ENDOTHELIUM;

AMIFOSTINE; APOPTOSIS; CELL CYCLE; CELL SURVIVAL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION PROFILING; HUMANS; MERCAPTOETHYLAMINES; RADIATION-PROTECTIVE AGENTS; ROC CURVE; TRANSCRIPTION, GENETIC;

EID: 4544365155     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2004.04.060     Document Type: Article

References (47)

1. Smoluk G.D., Fahey R.C., Calabro-Jones P.M., et al. Radioprotection of cells in culture by WR2721 and derivatives Form of the drug responsible for protection. Cancer Res. 48:1988;3641-3647
2. Giambarresi L., Jacobs A.J. Radioprotectants. Conklin J.J., Walker R.I. Military radiobiology. 1987;265-301 Academic Press, Orlando, FL
3. Murley J.S., Kataoka Y., Weydert C.J., et al. Delayed cytoprotection after enhancement of Sod2 (MnSOD) gene expression in SA-NH mouse sarcoma cells exposed to WR-1065, the active metabolite of amifostine. Radiat Res. 158:2002;101-109
4. Kataoka Y., Murley J.S., Khodarev N.N., et al. Activation of the nuclear transcription factor κB (NFκB) and differential gene expression in U87 glioma cells after exposure to the cytoprotector amifostine. Int J Radiat Oncol Biol Phys. 53:2001;180-189
5. Grdina D.J., Murley J.S., Kataoka Y., et al. Differential activation of nuclear transcription factor κB, gene expression, and proteins by amifostine's free thiol in human microvascular endothelial and glioma cells. Semin Radiat Oncol. 12:(Suppl. 1):2002;103-111
6. Liu S.C., Murley J.S., Woloschak G., et al. Repression of c-myc gene expression by the thiol and disulfide forms of the cytoprotector amifostine. Carcinogenesis. 18:1997;2457-2459
7. Woloschak G.E., Paunesku T., Dale P., et al. Expression of thymidine kinase RNA and a related transcript is modulated by the radioprotector WR-1065. Cancer Res. 55:1995;4788-4792
8. Murley J.S., Kataoka Y., Hallahan D.E., et al. Activation of NFκB and MnSOD gene expression by free radical scavengers in human microvascular endothelial cells. Free Rad Biol Med. 30:(12):2001;1426-1439
9. Shaw L.M., Bonner H.S., Schuchter L., et al. Pharmacokinetics of amifostine Effects of dose and method of administration. Semin Oncol. 26:(Suppl 7.):1999;34-36
10. Ho M., Yang E., Matcuk G., et al. Identification of endothelial cell genes by combined database mining and microarray analysis. Physiol Genomics. 13:2003;249-262
11. Brooks A.R., Lelkes P.I., Rubanyi G.M., et al. Gene expression profiling of human aortic endothelial cells exposed to disturbed flow and steady laminar flow. Physiol Genomics. 9:2002;27-41
12. Khodarev N.N., Yu J., Nodzenski E., et al. Tumor-endothelial interactions in co-culture Coordinated changes of gene expression profiles and phenotypic properties of endothelial cells. J Cell Sci. 116:2003;1013-1022
13. Carr K.M., Bittner M., Trent J.M. Gene-expression profiling in human cutaneous melanoma. Oncogene. 22:2003;3076-3080
14. Srivastava M., Eidelman O., Pollard H.B. Pharmacogenomics of the cystic fibrosis transmembrane conductance regulator (CFTR) and the cystic fibrosis drug CPX using genome microarray analysis. Mol Med. 5:1999;753-767
15. de Longueville F., Surry D., Meneses-Lorente G., et al. Gene expression profiling of drug metabolism and toxicology markers using a low density DNA microarray. Biochem Pharmacol. 64:2002;137-149
16. Reilly T.P., Bourdi M., Brady J.N., et al. Expression profiling of acetaminophen liver toxicity in mice using microarray technology. Biochem Biophys Res Commun. 282:2001;321-328
17. Ades E.W., Candal F.J., Swerlick R.A., et al. HMEC-1 Establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol. 99:(6):1992;683-690
18. Lee Y.W., Park H.J., Son K.W., et al. 2,2′ ′,4,6,6′ ′-Pentachlorobiphenyl (PCB 104) induces apoptosis of human microvascular endothelial cells through the caspase-dependent activation of CREB. Tox Appl Pharmaco. 189:2003;1-10
19. Porn-Ares M.I., Saido T.C., Andersson T., et al. Oxidized low-density lipoprotein induces calpain-dependent cell death and ubiquitination of caspase 3 in HMEC-1 endothelial cells. Biochem J. 374:2003;403-411
20. Dkhissi F., Lu H., Soria C., et al. Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells. Human Gene Ther. 14:2003;997-1008
21. Artwohl M., Roden M., Holzenbein T., et al. Modulation by leptin of proliferation and apoptosis in vascular endothelial cells. Int J Obesity. 26:2002;577-580
22. Grdina D.J., Murley J.S., Roberts J.C. Effects of thiols on topoisomerase-IIα activity and cell cycle proliferation. Cell Prolif. 31:1998;217-229
23. Freeman W.M., Robertson D.J., Vrana K.E. Fundamentals of DNA hybridization arrays for gene expression and analysis. Biotechniques. 29:2000;1042-1046
24. Khodarev N.N., Park J.O., Yu J., et al. Receiver operating characteristic analysis A general tool for DNA array data filtration and performance estimation. Genomics. 81:2003;202-209
25. Khodarev N.N., Park J.O., Yu J., et al. Dose dependent and independent temporal patterns of gene responses to ionizing radiation in normal and tumor cells and tumor xenografts. Proc Natl Acad Sci USA. 98:2001;12665-12670
26. Metz C.E., Herman B.A., Shen J.H. Maximum likelihood estimation of receiver operating characteristic (ROC) curves from continuously distributed data. Stat Med. 17:(9):1998;1033-1053
27. Bilban M., Buehler L.K., Head S., et al. Defining signal thresholds in DNA microarrays Exemplary application for invasive cancer. BMC Genomics. 3:2002;19-22
28. Parodi S., Muselli M., Fontana V., et al. ROC curves are a suitable and flexible tool for the analysis of gene expression profiles. Cytogenet Genome Res. 101:2003;90-91
29. Khodarev NN, Beckett M, Labay E, et al. STAT 1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc Natl Acad Sci USA 2004;101:1714-1719
30. Grdina D.J., Shigematsu N., Dale P., et al. Thiol and disulfide metabolites of the radiation protector and potential chemopreventive agent WR2721 are linked to both its anticytotoxic and antimutagenic mechanisms of action. Carcinogenesis. 16:1995;767-774
31. Meechan P.J., Haraf D.J., Diamond A.M., et al. Reversion of radiosensitivity in azacytidine treated xrs-5 cells does not result in full radioprotection by WR-1065. Int J Radiat Oncol Biol Phys. 23:1992;999-1002
32. Meechan P.J., Haraf D.J., Diamond A.M., et al. Varying levels of radioprotection from the effects of JANUS neutrons in repair deficient xrs-5 hamster cells treated with azacytidine. Radiat Res. 140:1994;437-440
33. Hulsewede J.W., Schulte-Frohlinde D. Radiation protection of E coli strain by cysteamine in the presence of oxygen. Int J Radiat Biol Relat Stud Phys Chem Med. 50:1986;861-869
34. Petin V.G., Matrenina V.L. Radioprotecting action of chemical compounds on gamma-irradiated yeast cells of various genotypes. Mol Gen Genet. 183:1981;152-157
35. St Croix B., Rago C., Velculescu V., et al. Genes expressed in human tumor endothelium. Science. 289:2000;1197-1202
36. Lal A., Lash A.E., Altschul S.F., et al. A public database for gene expression in human cancers. Cancer Res. 59:1999;5403-5407
37. Glienke J., Schmitt A.O., Pilarsky C., et al. Differential gene expression by endothelial cells in distinct angiogenic states. Eur J Biochem. 267:2000;2820-2830
38. Kahn J., Mehraban F., Ingle G., et al. Gene expression profiling in an in vitro model of angiogenesis. Am J Pathol. 156:2000;1887-1900
39. Chi J.T., Chang H.Y., Haraldsen G., et al. Endothelial cell diversity revealed by global expression profiling. Proc Natl Acad Sci USA. 100:2003;10623-10628
40. Kim J.H., Shim J.S., Lee S.K., et al. Microarray-based analysis of anti-angiogenic activity of demethoxycurcumin on human umbilical vein endothelial cells Crucial involvement of the down regulation of matrix metalloproteinase. Jpn J Cancer Res. 93:2002;1378-1385
41. Ramakrishnan N., Catravas G.N. N-(2-mercaptoethyl)-1,3-propanediamine (WR-1065) protects thymocytes from programmed cell death. J Immunol. 148:1992;1817-1821
42. Rubin D.B., Drab E.A., Kang H.J., et al. WR-1065 and radioprotection of vascular endothelial cells. I. Cell proliferation, DNA synthesis and damage. Radiat Res. 145:1996;210-216
43. Drab-Weiss E.A., Hansra I.K., Blazek E.R., et al. Aminothiols protect endothelial cell proliferation against inhibition by lipopolysaccharide. Shock. 10:1998;423-429
44. Mazur L., Augustynek A., Halicka H.D., et al. Induction of apoptosis in bone marrow cells after treatment of mice with WR2721 and gamma-rays Relationship to cell cycle. Cell Biol Tox. 19:2003;13-27
45. Mirowski M., Rozalski M., Krajewska U., et al. Induction of caspase 3 and modulation of some apoptotic genes in human acute promyelocytic leukemia HL-60 cells by carboplatin with amifostine. Polish J Pharmacol. 55:2003;227-234
46. Ribizzi I., Darnowski J.W., Goulette F.A., et al. Amifostine cytotoxicity and induction of apoptosis in a human myelodysplastic cell line. Leukemia Res. 24:2000;519-525
47. de Campos-Nebel M., Larripa I., Gonzalez-Cid M. Differential antigenotoxic and cytoprotective effect of amifostine in idarubicin-treated mice. Environ Mol Mutagenesis. 39:2002;3-9